BCR and leukemia: Herein, we explored the therapeutic potential of pterostilbene on various hematological malignancies, especially in BCR/ABL+ leukemia, and also explored the underlying molecular and cellular mechanism by which pterostilbene exerts its effects on these leukemic cells.